Metabolic Management
|
December 12, 2024

Exploring The Link Between Metabolism and Human Disease Progression

Medically Reviewed by
Updated On
December 13, 2024

For the past 50 years, the United States healthcare system has grappled with a rising tide of chronic disease at all ages. Some experts refer to four key conditions—type 2 diabetes mellitus, hypertension, cardiovascular disease, and obesity—as the “four horsemen of metabolic death.” 

Science increasingly reveals that these conditions share a common underlying thread: cellular metabolic dysregulation.

This disruption begins early in life and unfolds along a continuum shaped by lifestyle choices and toxic exposures, both known and unknown. For practitioners committed to integrative and preventive health, emphasizing the critical role of metabolism is essential for maintaining wellness and thwarting disease.

[signup]

Understanding Metabolism: More Than Just Energy Conversion

Metabolism encompasses complex biochemical processes that occur in every cell. As paraphrased from a conversation with Dr. Robert Lustig, who is the Professor emeritus of Pediatrics, Division of Endocrinology at the University of California, San Francisco (UCSF), we either “burn” macronutrients for energy and activity, or we utilize them as building blocks for growth and repair. 

Cellular functions such as hormone regulation, movement, cognition, and immune defense hinge on optimal metabolic balance. When functioning efficiently, metabolism converts food into usable energy, supports cellular processes, and manages waste byproducts effectively.

Think of a car engine burning gasoline to make energy, the waste is water, particulate matter, carbon monoxide and heat. If not properly disposed of, engines do not function well over time. Similarly, when metabolic pathways become disrupted, the body's cellular and tissue balance falters, leading to chronic inflammation and oxidative stress, all of which are precursors to chronic disease. 

Chronic inflammation and oxidative stress emerge, laying the groundwork for many chronic diseases. 

Why Is Metabolic Health Declining?

Modern lifestyle changes are driving metabolic dysfunction. As our diets shifted from minimally processed foods to a Western pattern high in refined carbohydrates, added sugars, and processed fats, the impact on metabolic health became increasingly evident. 

Sedentary behavior, chronic mental stress, and exposure to environmental toxins have compounded these challenges, forming a “stone soup” of factors that undermine metabolic function.

According to the Centers for Disease Control and Prevention (CDC), approximately 98 million American adults have prediabetes—often without knowing it—and 38 million have type 2 diabetes. Early detection is critical, as metabolic diseases typically develop slowly and quietly over years.

Insulin Resistance: The Early Warning Sign

Insulin resistance is one of the earliest and most telling signs of metabolic dysfunction. Insulin is the hormone responsible for allowing cells to absorb glucose from the bloodstream. The glucose can be used for conversion to either adenosine triphosphate (ATP) for energy, to be used as building blocks for cellular growth, or to be stored as triglycerides/fat for a rainy day. 

When cells become resistant to insulin’s action, glucose accumulates in the blood. 

The body responds by producing more insulin, leading to a cycle of elevated insulin, elevated glucose, and energy-starved cells. Over time, this condition increases the risk of developing type 2 diabetes, now affecting 38 million Americans

The modern American diet—rich in refined sugars and fats but low in fiber—drives insulin resistance by causing frequent spikes in blood sugar and compensatory insulin surges. 

Long before diabetes surfaces, insulin resistance silently contributes to inflammation, oxidative stress, and other issues that promote cardiovascular disease.

Metabolic Syndrome and Cardiovascular Disease

Insulin resistance is frequently associated with metabolic syndrome, a cluster of conditions including elevated blood pressure, abnormal lipid levels, and abdominal obesity. People with metabolic syndrome are two to three times more likely to develop cardiovascular disease than those without it. 

This heightened risk stems from chronic inflammation and oxidative stress, factors that damage blood vessels and facilitate atherosclerosis

Early detection through lab tests—such as fasting insulin, fasting glucose, and hemoglobin A1c—may help identify insulin resistance before it progresses to overt diabetes or cardiovascular complications. 

Similarly, measuring high-sensitivity C-reactive protein (hs-CRP), a marker of inflammation, can highlight cardiovascular risk even in individuals without other apparent metabolic abnormalities. 

Non-Alcoholic Fatty Liver Disease (NAFLD): A Growing Concern

NAFLD is linked closely to metabolic dysfunction, insulin resistance, and obesity, with excess fat sometimes accumulating in the liver silently. This can potentially progress to non-alcoholic steatohepatitis (NASH), fibrosis, or cirrhosis over time. 

As with other metabolic disorders, early detection is critical. Liver function tests—measuring ALT, AST, and GGT—may offer insights into early liver stress, giving providers and patients a chance to personalize interventions, potentially before severe damage occurs.

The Metabolic Link to Cancer

Obesity, insulin resistance, and chronic inflammation may be associated with the risk of certain cancers, including breast, colon, and liver cancers. 

Insulin acts as a growth signal, and persistently elevated levels in insulin-resistant states may potentially support tumor growth. In addition, chronic inflammation may foster an environment conducive to malignant changes. 

Recognizing these risk factors underscores the importance of maintaining metabolic balance as a preventive strategy.

Early Detection Through Strategic Lab Testing

Early detection is paramount. Routine tests like fasting glucose, hemoglobin A1c, fasting insulin, and comprehensive metabolic panels may reveal valuable insights into metabolic imbalances, potentially before symptoms emerge. 

More advanced tests, such as hs-CRP or genetic assessments, may help tailor preventive strategies. 

For those seeking specialized testing, options like Boston Heart and Access Med Labs (available through Rupa Health) may offer broader or more cost-effective panels. 

Providers should guide patients toward evidence-based choices that fit their unique metabolic profiles.

[signup]

The Good News: Prevention and Reversal Are Possible

Metabolic dysfunction—and the chronic diseases it underpins—is not inevitable. Lifestyle modifications and early interventions may help individuals better manage these conditions and support overall metabolic health.

By shifting focus from treating advanced disease to identifying metabolic imbalances early, healthcare providers can encourage meaningful lifestyle changes, improved nutrition, regular physical activity, and environmental adjustments. Over time, these changes can contribute to improved resilience and a reduced burden of chronic health challenges.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

CDC. (2020). National diabetes statistics report, 2017 estimates of diabetes and its burden in the United States background. In CDC. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf

Chew, N. W. S., Ng, C. H., Tan, D. J. H., Kong, G., Lin, C., Chin, Y. H., Lim, W. H., Huang, D. Q., Quek, J., Fu, C. E., Xiao, J., Syn, N., Foo, R., Khoo, C. M., Wang, J.-W., Dimitriadis, G. K., Young, D. Y., Siddiqui, M. S., Lam, C. S. P., & Wang, Y. (2023). The global burden of metabolic disease: Data from 2000 to 2019. Cell Metabolism, 35(3), 414-428.e3. https://doi.org/10.1016/j.cmet.2023.02.003

DeFronzo, R. A. (2009). From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 58(4), 773–795. https://doi.org/10.2337/db09-9028

Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., Lenfant, C., American Heart Association, & National Heart, Lung, and Blood Institute. (2004). Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation, 109(3), 433–438. https://doi.org/10.1161/01.CIR.0000111245.75752.C6

Heindel, J. J., Lustig, R. H., Howard, S., & Corkey, B. E. (2024). Obesogens: A unifying theory for the global rise in obesity. International Journal of Obesity (2005), 48, 449–460. https://doi.org/10.1038/s41366-024-01460-3

Hotamisligil, G. S. (2017). Inflammation, metaflammation and immunometabolic disorders. Nature, 542(7640), 177–185. https://doi.org/10.1038/nature21363

Lega, I. C., & Lipscombe, L. L. (2019). Review: Diabetes, obesity and cancer - pathophysiology and clinical implications. Endocrine Reviews, 41(1). https://doi.org/10.1210/endrev/bnz014

Libby, P. (2012). Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(9), 2045–2051. https://doi.org/10.1161/atvbaha.108.179705

Pisani, P. (2008). Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Archives of Physiology and Biochemistry, 114(1), 63–70. https://doi.org/10.1080/13813450801954451

Reaven, G. M. (2011). Insulin resistance: The link between obesity and cardiovascular disease. Medical Clinics of North America, 95(5), 875–892. https://doi.org/10.1016/j.mcna.2011.06.002

Ridker, P. M. (2003). C-Reactive protein. Circulation, 108(12). https://doi.org/10.1161/01.cir.0000093381.57779.67

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73–84. https://doi.org/10.1002/hep.28431

Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011). Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical Gastroenterology and Hepatology, 9(6), 524-530.e1. https://doi.org/10.1016/j.cgh.2011.03.020

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Metabolic Management
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.